Phibro Animal Health Corp (PAHC): who owns it and who trades it
As of Nov 16, 2026, PAHC insiders reported 97 open-market sales worth $24.6M and 1 purchase worth $318K in the last 12 months, with 100% of the sale value made under pre-set 10b5-1 plans. The largest seller was Jack Bendheim (CEO), with $12.4M. 4 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Phibro Animal Health
From the latest filingsOverall: more buying than selling. Insiders mostly bought. Funds and famous investors were close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns PAHC
209 funds and institutions reported PAHC shares worth $696M at the end of Q2 2026. The largest holder is BlackRock, Inc. with $101M.
10 largest owners, by value
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| BlackRock, Inc. | 3.22M | – | $101M | -1% |
| FMR LLC (Fidelity) | 3.16M | – | $99.2M | +45% |
| State Street Corp | 1.04M | – | $32.6M | +9% |
| Millennium Management LLC | 936,701 | – | $29.4M | +1578% |
| Vanguard Capital Management LLC | 923,318 | – | $29M | +4% |
| California State Teachers Retirement System | 891,980 | – | $28.4M | +3862% |
| Geode Capital Management, LLC | 657,350 | – | $20.6M | +9% |
| Lord, Abbett & Co. LLC | 653,305 | – | $20.5M | +64% |
| Dimensional Fund Advisors LP | 531,087 | – | $16.7M | +5% |
| Vanguard Portfolio Management LLC | 508,486 | – | $16M | +4% |
| Renaissance Technologies LLC | 480,500 | – | $15.1M | -17% |
| CastleKnight Management LP | 461,322 | – | $14.5M | +508% |
| Morgan Stanley | 412,634 | – | $13M | +5% |
| Dana Investment Advisors, Inc. | 387,867 | – | $12.2M | +35% |
| Invesco Ltd. | 336,329 | – | $10.6M | +2% |
| Nuveen, LLC | 314,079 | – | $9.9M | -31% |
| Oberweis Asset Management Inc/ | 311,100 | – | $9.8M | +12% |
| Ranger Investment Management, L.P. | 292,410 | – | $9.2M | +5% |
| Charles Schwab Investment Management Inc | 260,861 | – | $8.2M | -1% |
| Sixth Street Partners Management Company, L.P. | 260,861 | – | $8.2M | – |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, PAHC insiders reported $318K of open-market purchases and $24.6M of sales. 100% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| May 29, 2026 | E Thomas Corcoran | Director | Purchase | 10,000 | $31.77 | $318K | Form 4 |
| May 7, 2026 | Jack Bendheim +1 | CEO | Sale plan | 2,029 | $49.19 | $99.8K | Form 4 |
| May 7, 2026 | Jack Bendheim +1 | CEO | Sale plan | 1,149 | $48.31 | $55.5K | Form 4 |
| May 7, 2026 | Jack Bendheim +1 | CEO | Sale plan | 1,350 | $47.59 | $64.2K | Form 4 |
| May 6, 2026 | Jack Bendheim +1 | CEO | Sale plan | 5,634 | $57.18 | $322K | Form 4 |
| May 6, 2026 | Jack Bendheim +1 | CEO | Sale plan | 1,406 | $58.13 | $81.7K | Form 4 |
| May 5, 2026 | Jack Bendheim +1 | CEO | Sale plan | 6,264 | $55.73 | $349K | Form 4 |
| May 5, 2026 | Jack Bendheim +1 | CEO | Sale plan | 776 | $56.37 | $43.7K | Form 4 |
| Apr 30, 2026 | Jack Bendheim +1 | CEO | Sale plan | 1,235 | $53.32 | $65.9K | Form 4 |
| Apr 30, 2026 | Jack Bendheim +1 | CEO | Sale plan | 5,805 | $52.65 | $306K | Form 4 |
| Apr 29, 2026 | Jack Bendheim +1 | CEO | Sale plan | 3,038 | $53.21 | $162K | Form 4 |
| Apr 29, 2026 | Jack Bendheim +1 | CEO | Sale plan | 4,002 | $52.70 | $211K | Form 4 |
| Apr 28, 2026 | Jack Bendheim +1 | CEO | Sale plan | 4,591 | $56.06 | $257K | Form 4 |
| Apr 28, 2026 | Jack Bendheim +1 | CEO | Sale plan | 1,652 | $55.10 | $91K | Form 4 |
| Apr 28, 2026 | Jack Bendheim +1 | CEO | Sale plan | 797 | $56.69 | $45.2K | Form 4 |
| Apr 23, 2026 | Jack Bendheim +1 | CEO | Sale plan | 421 | $54.56 | $23K | Form 4 |
| Apr 23, 2026 | Jack Bendheim +1 | CEO | Sale plan | 6,619 | $54.07 | $358K | Form 4 |
| Apr 22, 2026 | Jack Bendheim +1 | CEO | Sale plan | 7,040 | $54.29 | $382K | Form 4 |
| Apr 21, 2026 | Jack Bendheim +1 | CEO | Sale plan | 1,625 | $55.35 | $89.9K | Form 4 |
| Apr 21, 2026 | Jack Bendheim +1 | CEO | Sale plan | 5,415 | $56.17 | $304K | Form 4 |
| Apr 16, 2026 | BFI Co., LLC +1 | 10% owner | Sale plan | 5,190 | $54.56 | $283K | Form 4 |
| Apr 16, 2026 | BFI Co., LLC +1 | 10% owner | Sale plan | 1,850 | $54.88 | $102K | Form 4 |
| Apr 15, 2026 | BFI Co., LLC +1 | 10% owner | Sale plan | 2,623 | $56.27 | $148K | Form 4 |
| Apr 15, 2026 | BFI Co., LLC +1 | 10% owner | Sale plan | 3,618 | $57.21 | $207K | Form 4 |
| Apr 15, 2026 | BFI Co., LLC +1 | 10% owner | Sale plan | 799 | $58.11 | $46.4K | Form 4 |
| Apr 14, 2026 | BFI Co., LLC +1 | 10% owner | Sale plan | 6,548 | $59.03 | $387K | Form 4 |
| Apr 14, 2026 | BFI Co., LLC +1 | 10% owner | Sale plan | 492 | $59.69 | $29.4K | Form 4 |
| Mar 31, 2026 | Jack Bendheim +1 | CEO | Sale plan | 6,609 | $53.87 | $356K | Form 4 |
| Mar 31, 2026 | Jack Bendheim +1 | CEO | Sale plan | 431 | $54.35 | $23.4K | Form 4 |
| Mar 30, 2026 | Jack Bendheim +1 | CEO | Sale plan | 6,423 | $53.54 | $344K | Form 4 |
| Mar 30, 2026 | Jack Bendheim +1 | CEO | Sale plan | 617 | $54.31 | $33.5K | Form 4 |
| Mar 26, 2026 | Jack Bendheim +1 | CEO | Sale plan | 6,760 | $56.79 | $384K | Form 4 |
| Mar 26, 2026 | Jack Bendheim +1 | CEO | Sale plan | 280 | $57.17 | $16K | Form 4 |
| Mar 25, 2026 | Jack Bendheim +1 | CEO | Sale plan | 4,916 | $56.00 | $275K | Form 4 |
| Mar 25, 2026 | Jack Bendheim +1 | CEO | Sale plan | 552 | $56.86 | $31.4K | Form 4 |
| Mar 25, 2026 | Jack Bendheim +1 | CEO | Sale plan | 1,572 | $55.28 | $86.9K | Form 4 |
| Mar 24, 2026 | Jack Bendheim +1 | CEO | Sale plan | 6,523 | $52.88 | $345K | Form 4 |
| Mar 24, 2026 | Jack Bendheim +1 | CEO | Sale plan | 517 | $53.59 | $27.7K | Form 4 |
| Mar 19, 2026 | Jack Bendheim +1 | CEO | Sale plan | 124 | $53.24 | $6.6K | Form 4 |
| Mar 19, 2026 | Jack Bendheim +1 | CEO | Sale plan | 1,939 | $51.78 | $100K | Form 4 |
| Mar 19, 2026 | Jack Bendheim +1 | CEO | Sale plan | 4,977 | $52.79 | $263K | Form 4 |
| Mar 18, 2026 | Jack Bendheim +1 | CEO | Sale plan | 4,311 | $51.80 | $223K | Form 4 |
| Mar 18, 2026 | Jack Bendheim +1 | CEO | Sale plan | 3,598 | $53.03 | $191K | Form 4 |
| Mar 18, 2026 | Jack Bendheim +1 | CEO | Sale plan | 2,651 | $53.64 | $142K | Form 4 |
| Mar 17, 2026 | Jack Bendheim +1 | CEO | Sale plan | 5,280 | $51.66 | $273K | Form 4 |
| Mar 13, 2026 | Jack Bendheim +1 | CEO | Sale plan | 5,280 | $48.91 | $258K | Form 4 |
| Feb 26, 2026 | BFI Co., LLC +1 | 10% owner | Sale plan | 711 | $54.28 | $38.6K | Form 4 |
| Feb 26, 2026 | BFI Co., LLC +1 | 10% owner | Sale plan | 6,329 | $53.67 | $340K | Form 4 |
| Feb 25, 2026 | BFI Co., LLC +1 | 10% owner | Sale plan | 7,040 | $51.71 | $364K | Form 4 |
| Feb 24, 2026 | BFI Co., LLC +1 | 10% owner | Sale plan | 5,889 | $51.27 | $302K | Form 4 |
| Feb 24, 2026 | BFI Co., LLC +1 | 10% owner | Sale plan | 1,151 | $51.88 | $59.7K | Form 4 |
| Feb 20, 2026 | BFI Co., LLC +1 | 10% owner | Sale plan | 6,643 | $51.38 | $341K | Form 4 |
| Feb 20, 2026 | BFI Co., LLC +1 | 10% owner | Sale plan | 397 | $51.96 | $20.6K | Form 4 |
| Feb 19, 2026 | BFI Co., LLC +1 | 10% owner | Sale plan | 7,040 | $50.26 | $354K | Form 4 |
| Feb 18, 2026 | BFI Co., LLC +1 | 10% owner | Sale plan | 216 | $51.97 | $11.2K | Form 4 |
| Feb 18, 2026 | BFI Co., LLC +1 | 10% owner | Sale plan | 6,824 | $51.38 | $351K | Form 4 |
| Feb 13, 2026 | BFI Co., LLC +1 | 10% owner | Sale plan | 7,040 | $51.96 | $366K | Form 4 |
| Feb 11, 2026 | Jack Bendheim +1 | CEO | Sale plan | 13,950 | $51.61 | $720K | Form 4 |
| Feb 11, 2026 | Jack Bendheim +1 | CEO | Sale plan | 234 | $52.21 | $12.2K | Form 4 |
| Feb 10, 2026 | Jack Bendheim +1 | CEO | Sale plan | 50,994 | $51.76 | $2.6M | Form 4 |
| Feb 10, 2026 | Jack Bendheim +1 | CEO | Sale plan | 7,020 | $52.17 | $366K | Form 4 |
| Feb 5, 2026 | BFI Co., LLC +1 | 10% owner | Sale plan | 409 | $44.47 | $18.2K | Form 4 |
| Feb 5, 2026 | BFI Co., LLC +1 | 10% owner | Sale plan | 3,640 | $45.42 | $165K | Form 4 |
| Feb 5, 2026 | BFI Co., LLC +1 | 10% owner | Sale plan | 19,138 | $49.57 | $949K | Form 4 |
| Feb 5, 2026 | BFI Co., LLC +1 | 10% owner | Sale plan | 46,275 | $48.65 | $2.3M | Form 4 |
| Feb 5, 2026 | BFI Co., LLC +1 | 10% owner | Sale plan | 38,209 | $47.91 | $1.8M | Form 4 |
| Feb 5, 2026 | BFI Co., LLC +1 | 10% owner | Sale plan | 3,171 | $46.68 | $148K | Form 4 |
| Feb 4, 2026 | Jack Bendheim +1 | CEO | Sale plan | 3,520 | $41.15 | $145K | Form 4 |
| Feb 3, 2026 | Jack Bendheim +1 | CEO | Sale plan | 6,689 | $41.25 | $276K | Form 4 |
| Feb 3, 2026 | Jack Bendheim +1 | CEO | Sale plan | 2,971 | $41.97 | $125K | Form 4 |
| Jan 30, 2026 | BFI Co., LLC +1 | 10% owner | Sale plan | 6,693 | $40.09 | $268K | Form 4 |
| Jan 29, 2026 | BFI Co., LLC +1 | 10% owner | Sale plan | 6,772 | $40.12 | $272K | Form 4 |
| Jan 23, 2026 | Jack Bendheim +1 | CEO | Sale plan | 1,235 | $40.55 | $50.1K | Form 4 |
| Jan 22, 2026 | Jack Bendheim +1 | CEO | Sale plan | 1,283 | $42.68 | $54.8K | Form 4 |
| Jan 22, 2026 | Jack Bendheim +1 | CEO | Sale plan | 11,875 | $41.91 | $498K | Form 4 |
| Jan 21, 2026 | Jack Bendheim +1 | CEO | Sale plan | 14,687 | $41.68 | $612K | Form 4 |
| Jan 15, 2026 | BFI Co., LLC +1 | 10% owner | Sale plan | 2,932 | $40.02 | $117K | Form 4 |
| Jan 14, 2026 | BFI Co., LLC +1 | 10% owner | Sale plan | 393 | $41.14 | $16.2K | Form 4 |
| Jan 14, 2026 | BFI Co., LLC +1 | 10% owner | Sale plan | 3,258 | $40.46 | $132K | Form 4 |
| Jan 13, 2026 | BFI Co., LLC +1 | 10% owner | Sale plan | 7,551 | $40.32 | $304K | Form 4 |
| Jan 9, 2026 | BFI Co., LLC +1 | 10% owner | Sale plan | 213 | $40.16 | $8.6K | Form 4 |
| Jan 7, 2026 | Jack Bendheim +1 | CEO | Sale plan | 328 | $40.09 | $13.1K | Form 4 |
| Dec 11, 2025 | BFI Co., LLC +1 | 10% owner | Sale plan | 2,757 | $40.61 | $112K | Form 4 |
| Dec 11, 2025 | BFI Co., LLC +1 | 10% owner | Sale plan | 2,995 | $41.22 | $123K | Form 4 |
| Dec 9, 2025 | Jack Bendheim +1 | CEO | Sale plan | 1,288 | $40.19 | $51.8K | Form 4 |
| Dec 8, 2025 | Jack Bendheim +1 | CEO | Sale plan | 3,520 | $40.06 | $141K | Form 4 |
| Dec 4, 2025 | BFI Co., LLC +1 | 10% owner | Sale plan | 3,152 | $41.16 | $130K | Form 4 |
| Dec 4, 2025 | BFI Co., LLC +1 | 10% owner | Sale plan | 368 | $41.75 | $15.4K | Form 4 |
| Dec 3, 2025 | BFI Co., LLC +1 | 10% owner | Sale plan | 3,520 | $40.77 | $144K | Form 4 |
| Dec 1, 2025 | BFI Co., LLC +1 | 10% owner | Sale plan | 3,520 | $41.66 | $147K | Form 4 |
| Nov 28, 2025 | BFI Co., LLC +1 | 10% owner | Sale plan | 3,520 | $42.54 | $150K | Form 4 |
| Nov 26, 2025 | BFI Co., LLC +1 | 10% owner | Sale plan | 5,280 | $44.02 | $232K | Form 4 |
| Nov 25, 2025 | BFI Co., LLC +1 | 10% owner | Sale plan | 7,040 | $43.93 | $309K | Form 4 |
| Nov 20, 2025 | BFI Co., LLC +1 | 10% owner | Sale plan | 3,459 | $41.75 | $144K | Form 4 |
| Nov 20, 2025 | BFI Co., LLC +1 | 10% owner | Sale plan | 61 | $42.32 | $2.6K | Form 4 |
| Nov 18, 2025 | BFI Co., LLC +1 | 10% owner | Sale plan | 20 | $44.28 | $886 | Form 4 |
| Nov 18, 2025 | BFI Co., LLC +1 | 10% owner | Sale plan | 5,260 | $43.82 | $230K | Form 4 |
| Nov 17, 2025 | BFI Co., LLC +1 | 10% owner | Sale plan | 5,280 | $44.56 | $235K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Jack Bendheim | President and CEO, Director, 10% owner | – | $12.4M | May 7, 2026 |
| BFI Co., LLC | 10% owner | – | $12.2M | Apr 16, 2026 |
| E Thomas Corcoran | Director | $318K | – | May 29, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
PAHC short interest
1.02M PAHC shares are sold short. Over the last 12 reports the number of shares short went down 14%.
As of Oct 30, 2026, 1.02M PAHC shares were sold short, down 1.3% from the report before. At the average daily volume of 158,839 shares, buying them all back would take about 6.4 trading days (days to cover).
Shares short
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 1.02M | – | -1% | 158,839 | 6.4 |
| Oct 15, 2026 | 1.03M | – | +1% | 239,451 | 4.3 |
| Sep 30, 2026 | 1.02M | – | -11% | 251,629 | 4.1 |
| Sep 15, 2026 | 1.14M | – | -6% | 233,563 | 4.9 |
| Aug 31, 2026 | 1.21M | – | -2% | 246,761 | 4.9 |
| Aug 14, 2026 | 1.23M | – | +3% | 169,708 | 7.3 |
| Jul 31, 2026 | 1.19M | – | -2% | 212,386 | 5.6 |
| Jul 15, 2026 | 1.22M | – | +0% | 320,282 | 3.8 |
| Jun 30, 2026 | 1.22M | – | -1% | 287,446 | 4.2 |
| Jun 15, 2026 | 1.23M | – | +12% | 355,556 | 3.5 |
| May 29, 2026 | 1.10M | – | -7% | 357,582 | 3.1 |
| May 15, 2026 | 1.18M | – | -3% | 584,068 | 2.0 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Phibro Animal Health company events
Phibro Animal Health filed 13 reports on Form 8-K in the last 12 months, 3 of them about an important change (leadership). The latest was on Nov 4, 2026.
- Nov 4, 2026ResultsReleased financial results. Filing
- Nov 3, 2026AnnouncementPhibro Animal Health Corporation issued a press release announcing the declaration of a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on December 16, 2026, to stockholders of record at the close of business on November 25, 2026. Filing
- Aug 26, 2026ResultsReleased financial results. Filing
- Jul 28, 2026AnnouncementPhibro Animal Health Corporation issued a press release announcing the declaration of a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on September 23, 2026, to stockholders of record at the close of business on September 2, 2026. Filing
- Jun 26, 2026LeadershipIn connection with Daniel (Dani) Bendheim’s appointment to the role of Chief Executive Officer and President of the Company effective July 1, 2026, the Compensation Committee of the Board of Directors of Phibro Animal Health Corporation approved (i) the Company’s entry into an employment agreement… Filing
- May 6, 2026ResultsReleased financial results. Filing
- May 5, 2026AnnouncementPhibro Animal Health Corporation issued a press release announcing the declaration of a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on June 24, 2026, to stockholders of record at the close of business on June 3, 2026. Filing
- Apr 30, 2026AgreementPhibro Animal Health Corporation entered into Amendment No. 1 to its Credit Agreement with Coöperatieve Rabobank U.A., New York Branch, as administrative agent, collateral agent and L/C issuer, and each lender from time to time party thereto, which amends the Credit Agreement, dated as of July 3… Filing
- Apr 27, 2026AnnouncementShared information with investors. Filing
- Apr 14, 2026LeadershipMs. Joyce J. Lee, a member of the Board of the Directors of Phibro Animal Health Corporation, informed the Company that she intends to resign from her position as Director of the Company effective April 15, 2026. Filing
- Feb 4, 2026ResultsReleased financial results. Filing
- Feb 3, 2026AnnouncementPhibro Animal Health Corporation issued a press release announcing the declaration of a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on March 25, 2026, to stockholders of record at the close of business on March 4, 2026. Filing
- Dec 18, 2025LeadershipPhibro Animal Health Corporation announced that Jack C. Bendheim, the current Chairman of the Board of Directors of the Company, Chief Executive Officer and President, will resign from his position as Chief Executive Officer and President, effective July 1, 2026. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Phibro Animal Health financials
Famous investors that hold PAHC
4 of the 50 well-known investors we track reported holding PAHC in their latest 13F filing. The largest position is Israel Englander's, worth $29.4M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Israel Englander · Millennium Management | Q3 2026 | 822,639 | $29.4M | 0.0% | -12% |
| Jim Simons · Renaissance Technologies | Q3 2026 | 437,000 | $15.6M | 0.0% | -9% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 72,654 | $2.6M | 0.0% | +388% |
| Steve Cohen · Point72 Asset Management | Q3 2026 | 36,493 | $1.3M | 0.0% | New |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named PAHC in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Oct 19, 2026 | Millennium Management LLC | 13G/A | 3.9% |
| Oct 19, 2026 | Millennium Management LLC | 13G/A | 3.9% |
Questions about Phibro Animal Health Corp (PAHC) stock
Who owns the most PAHC stock?
The largest reported owner of Phibro Animal Health Corp (PAHC) is BlackRock, Inc.. In total, 209 funds and institutions reported holding PAHC at the end of Q2 2026. See the largest owners.
Are PAHC insiders buying or selling?
In the last 12 months, PAHC insiders reported 1 open-market purchase worth $318K and 97 sales worth $24.6M. The latest trade was on May 29, 2026. See every trade.
What is the short interest in PAHC?
As of Oct 30, 2026, 1.02M PAHC shares were sold short, down 1.3% from the report before. At the average daily volume of 158,839 shares, buying them all back would take about 6.4 trading days (days to cover). See the history.
Which famous investors hold PAHC?
4 of the 50 well-known investors we track reported PAHC in their latest 13F filing, including Israel Englander, Jim Simons, Ken Griffin. The largest position is worth $29.4M. See all holders.
Executive pay
Phibro Animal Health's chief executive was paid a total of $5.2M for the year ended Jun 30, 2026, down 1% from $5.3M the year before. In the last 12 months, Phibro Animal Health's executives and directors bought $318K of stock on the open market and sold $12.4M.
From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.